|
|
||||||||
1 From the Schepens Eye Research Institute and 2 Harvard Medical School, Boston; and 3 R&D Consulting, Arlington, Massachusetts.
| Abstract |
|---|
|
|
|---|
METHODS. Spectrophotometric measurements were made at the fovea and 7° temporal to the fovea in 145 normal subjects (age range, 1580 years). Spatial distribution along the four cardinal meridians was measured in selected subjects by both spectrophotometry and autofluorescence imaging. To minimize contributions of extraneous fluorophores, macular pigment, and melanin, all measurements used excitation at 550 nm, integrating emission between 650 and 750 nm.
RESULTS. Lipofuscin fluorescence increased linearly until age 70, then declined.
The rate of accumulation was significantly slower in the fovea than at
the temporal site; accumulation rates in vivo were greater than
previously observed in microscopic studies. Fluorescence was
40%
lower in the fovea than at 7° eccentricity and was asymmetrically
distributed around the fovea. The fluorescence was maximal at
11°
temporally,
7° nasally,
13° superiorly, and
9°
inferiorly. At the same eccentricity, fluorescence was always less
along the inferior meridian than along any other.
CONCLUSIONS. Light absorption by RPE melanin can explain differences between the in vivo and ex vivo estimates of the rate of lipofuscin accumulation. Declining fluorescence at old age may represent removal of atrophic RPE cells. The spatial distribution of lipofuscin generally matches that of rods and reflects, rather than predicts, the pattern of age-related loss of rod photoreceptors.
| Introduction |
|---|
|
|
|---|
The association between lipofuscin accumulation and retinal degeneration is most clearly delineated in Stargardts macular dystrophy, an inherited retinal degeneration characterized by high levels of lipofuscin,8 and caused by defects in the ABCR gene (Rim protein)9 10 expressed specifically in rods and cones.11 Lipofuscin levels in patients with Stargardts macular dystrophy were found to be significantly higher than those in normal subjects of the same age.12 13 Excessive lipofuscin accumulation preceded photoreceptor loss in mice carrying null mutations in the ABCR gene.14 Furthermore, loss of visual function in other inherited retinal degenerations such as vitelliform macular dystrophy (Bests disease)15 and Battens disease (ceroid-lipofuscinosis)16 has also been attributed to excessive accumulation of lipofuscin-like materials in lysosomes of the RPE.
Lipofuscin is potentially noxious, for it acts as a photosensitizer in blue light, generating free radicals both in isolated granules17 18 and within the RPE cell.19 Lipofuscin contains several distinct fluorescent components,20 one of which is A2E, a pyridinium bisretinoid.21 22 The precursor of A2E is formed in the photoreceptor from sequential reactions of phosphatidylethanolamine and two molecules of vitamin A; subsequent hydrolysis releases A2E.23 24 This red-emitting fluorophore of lipofuscin also has noxious effects on RPE cells in vitro: it inhibits lysosomal digestion of proteins,25 and causes blue-lightmediated disruption of lysosomal membranes26 and RPE apoptosis.27 Lipofuscin colocalizes with lysosomal enzymes in neurons,28 29 and exogenous A2E is delivered to lysosomes of RPE cells in vitro.30 If released into the cytoplasm, A2E selectively attacks mitochondria and releases cytochrome C and AIF (apoptosis-inducing factor), which initiate apoptosis.31 Subsequent removal of apoptopic RPE could explain the reduced levels of lipofuscin observed in eyes with advanced Bests disease32 and AMD.6 33
To probe the relationship between lipofuscin accumulation and photoreceptor loss with age, and in macular degenerations, we and others developed spectrophotometric and imaging techniques to study lipofuscin fluorescence in vivo.34 35 36 Using spectrophotometry,37 we have demonstrated that the spectrum of the dominant fundus fluorophore is consistent with that of chloroform extracts of lipofuscin-laden human RPE cells4 and with that of the lipofuscin fluorophore VIII identified by Eldred and Katz20 and subsequently shown to be A2E.21 22 Additionally, the spectrum of elevated fluorescence in patients with Stargardts disease corresponds with that in normal subjects.12 In this report we characterize the rate of accumulation of lipofuscin at different sites in the posterior pole and compare these rates with previously reported data from ex vivo1 38 39 and in vivo12 37 40 studies. If lipofuscin is a marker for areas of the fundus at great risk for pathology, it would be important to know what mechanisms produce its distribution. Lipofuscin distribution along the horizontal meridian has only been characterized with low spatial resolution, but the distribution along the vertical meridian is not known. We also investigate how lipofuscin is spatially distributed across the fundus, tested whether there are age-related changes in distribution, and compared the distribution of lipofuscin with published distributions of photoreceptors,41 42 macular pigment,43 and lesions in ARM.44 The ultimate goal of our research is to evaluate whether peak levels of lipofuscin identify eyes at high risk for subsequent photoreceptor loss and to determine whether focal decreases in lipofuscin content identify regions where photoreceptor loss is occurring.
| Methods |
|---|
|
|
|---|
|
Spectrophotometry
Data were acquired by fundus spectrophotometry34
according to established protocols.47
The subjects pupil
was aligned under infrared illumination, and the fundus was observed
with 540 to 620-nm light. Excitation light, derived from a Xenon arc
lamp with an excitation filter centered at 550 nm (FWHM, 20 nm),
irradiated a 3° diameter retinal field during 180 ms (radiant
exposures, 1017 mJ/cm2). The fluorescence was
collected from a sampling field (centered in the excitation field) with
a diameter of 2° (585 µm). After rejection of reflected excitation
light by a barrier filter, the fluorescence was spectrally analyzed by
an optical multichannel analyzer (Princeton Applied Research, Trenton,
NJ) producing an emission spectrum with a spectral resolution of 6 nm.
The contribution of lens fluorescence and scatter was
measured34
in each subject and subtracted from the fundus
fluorescence spectrum (this correction was <5% for the population
studied here).
An internal fixation was used to direct the subjects fixation for
sites within 7° from the fovea. External fixations were used for
measurements at larger eccentricities, 10 to 30°, and test sites were
marked on a fundus photograph. Each measurement was preceded by a
510-nm bleaching exposure of 7.1 log photopic trolands for 2 seconds,
sufficient to bleach 99.8% of the cones and >85% of the
rods;48
; the error in the fluorescence measurement
resulting from this incomplete rhodopsin bleach is
3% (compared
with
20% if we did not bleach). As much as possible, large vessels
were avoided by slight displacements, and focus and pupil position were
readjusted before each measurement.
Fluorescence Imaging
Images of fundus autofluorescence centered on the fovea were
obtained with a modified fundus camera (TRC-FE; Topcon Corp., Tokyo,
Japan) coupled to a CCD camera.36
The retinal field was
restricted to a 13°-diameter circle to minimize contributions of
light scattering and fluorescence from the crystalline lens. Alignment
and focusing was performed under 550-nm illumination. Fluorescence
images were obtained with flash settings of 300 W·sec using 470- and
550-nm excitation filters (FWHM
30 nm) and matched barrier filters.
Retinal exposure for autofluorescence imaging was 3 to 5
mJ/cm2 (duration, 12 msec). Retinal images were
recorded with a cooled scientific grade CCD camera (768 x 512
pixels, MicroMax; Princeton Instruments, Trenton, NJ). Areas of 2 x 2 pixels were combined to 1 pixel; the size of this pixel was 15.6
µm at the retina. Gray levels for fundus fluorescence were typically
50 to 200.
Correction for Lens Absorption
Because the fluorescence excitation and emission are affected by
crystalline lens absorption, and because the latter is strongly
affected by age,49
50
it is necessary to individually
correct the fluorescence data to account for the loss of light in the
lens. This is achieved by using a previously described reflectometry
method.46
In essence, a reflectance spectrum was recorded
at 7° temporal to the fovea using the same optical path in the eye as
for the fluorescence measurements. The difference in the
log-reflectances at 520 and 485 nm is equal to the difference of 2
terms: (1) the difference in log-reflectances at the same wavelengths
in absence of ocular media, and (2) two times the lens optical density
difference between 485 and 520 nm (double pass). Assuming that the
first term is unaffected by age (or that its age variation is small
compared with that of the second term) and using known extinction
coefficients for the lens,49
one can derive the lens
optical density at 510 nm relative to the mean lens density at an age
of 44 years. The relative lens optical densities estimated by this
method vary between -0.15 to 0.4 DU at 510 nm, are reproducible within
0.05 DU, are not affected by ocular pigmentation, and are not
statistically different from lens optical densities determined
psychophysically in the same subjects.46
Data Analysis
All fluorescence spectra were individually corrected for the
excitation energies, for the spectral sensitivity of the detecting
system,34
and for the absorption by the crystalline lens
(see above). Emission spectra, obtained with an excitation at 550 nm,
were integrated between 650 and 750 nm to yield the fluorescence
measure (fluorescence units [FU] are in
µJ·sr-1/J). Although the emission spectrum
extends from 550 to 800 nm with a maximum at
640 nm (Exc, 550
nm),37
we used only the emission above 650 nm, to minimize
contributions from secondary fluorophores.51
The
excitation at 550 nm (FWHM, 20 nm) is minimally affected by macular
pigment absorption: optical density of the macular pigment is generally
<1 DU at 460 nm and therefore < 0.015 DU (3% absorption) at 550
nm.52
Absorption by RPE melanin should also be minimized
by the choice of excitation and detection wavelengths because the
absorption by melanin decreases monotonically throughout the visible
spectrum.53
Autofluorescence images at 470- and 550-nm excitation were analyzed using the IGOR image analysis software (WaveMetrics, Lake Oswego, OR). The 550- and 470-nm images were aligned using translations and matching the position of retinal landmarks in the superimposed images. The position of the center of the fovea was defined as the location with lowest fluorescence in the 470-nm image; this corresponds with the location of the highest macular pigment density (highest concentration of cones). Horizontal and vertical profiles through the center of the fovea, averaged over 5 pixels (77 µm), were calculated for the 550-nm images and normalized to the average level in a 2° diameter circle centered on the fovea. Maximal eccentricity was 4.5°, avoiding areas of nonuniformity of excitation at the edges of the 13° diameter image.
| Results |
|---|
|
|
|---|
1.25 at age 65 and a factor
0.89
at age 25.
|
Lipofuscin fluorescence, corrected for lens absorption (Fig. 2) , exhibited a significant positive correlation with age (r = 0.73 and r = 0.69 for the temporal site and the fovea, respectively; P < 0.0001). The fluorescence in the fovea was significantly less than that at 7° temporal to the fovea (P < 0.0001, paired t-test, two-tailed), being on average 61% ± 9% of the value at 7° temporal. The fluorescence increased quasi-linearly up to approximately 70 years of age and then decreased in older subjects.
|
2.8 times greater than that at age 25 for both sites; this
ratio would be
2.0 for fluorescences not corrected for lens
absorption (see above).
|
The fluorescence exhibited a tendency to decline above age
70 years
(Fig. 2)
; the rate of decline was estimated by regression analysis for
the 23 subjects over age 70. The slopes of the regression lines for the
temporal site and the fovea were -0.86 and -0.63 FU/y, respectively
(Table 2)
, not significantly different from each other. Both slopes
were significantly smaller than the rate of accumulation for ages < 70 years (P < 0.0001). Similar decreases in the
accumulation rate were found at 7° eccentricity along the superior,
inferior, and nasal meridians in 10 subjects over age 70 (Table 1)
. The
slopes were about -1.5 FU/y and were also significantly smaller than
the accumulation rates for ages < 70 years of age
(P < 0.01).
The fluorescence measurements at the five sites (fovea and 7° from the fovea on each meridian) were highly correlated with each other (r > 0.88, n = 37, P < 0.0001, for all possible combinations). After accounting for the age dependence at each site, the "remaining variation in fluorescence" was still highly correlated between the five sites (r > 0.83, P < 0.0001). This means that if the fluorescence was high or low at one site for a given age, it was also high or low at the other sites. The same intraindividual correspondence was seen in the high interocular correlation in fluorescence found in 10 subjects (P < 0.0005 for both sites); there was no significant difference between the estimates in both eyes (paired, both P > 0.2).
Spatial Distribution
Spatial distributions were measured in three subgroups of subjects
(Table 1) using spectrophotometry in four sites at 7° from the fovea
on the four meridians (subgroup A), using fluorescence imaging in a
central 9° diameter circle (subgroup B) and using spectrophotometry
along the four meridians at eccentricities between 7 and 30°
(subgroup C). Measurements in each subgroup included a measurement at
the fovea. Fluorescence at each eccentricity was expressed as
(r), the ratio of the fluorescence at eccentricity
r (in degrees) and that at the fovea. Positive
eccentricities are for the temporal and superior directions and
negative for the nasal and inferior directions.
Subgroup A.
The spectrophotometric ratios
(±7°) in the four cardinal
directions in 37 subjects were all significantly different from each
other (Table 3
; subgroup A). The fluorescence was highest temporally, then
nasally, superiorly, and lowest inferiorly. Values at eccentricity were
all significantly larger than at the fovea (P <
0.001). The ratios
(±7°) were not significantly
influenced by ocular pigmentation (as judged by iris color,
P > 0.5). Comparing only the sites at 7°
eccentricity, one finds no correlation with age for the ratios of nasal
to temporal (
= -0.19; P = 0.2) and superior
to temporal (
= -0.0; P = 0.9) fluorescence,
but a significant negative correlation ratio of inferior to superior
fluorescence (
= -0.43; P = 0.009). Linear
regression of the difference between the inferior and superior
fluorescences with age suggests that the fluorescences are about equal
at age 25 (difference = 0.5 ± 0.7 FU; P =
0.4) but that it then increases less rapidly in the inferior than in
the superior fundus (P = 0.005).
|
(±4) = 1.07 - 1.58).
Average results for
(2°) and
(4°) are given in
Table 3
(subgroup B). The relative distribution of fluorescence
along the meridians follow a pattern similar to that seen at 7° from
the fovea (subgroup A): fluorescence is highest temporally and lowest
inferiorly. Statistical differences in
at the same eccentricity
were most pronounced between the temporal and inferior meridians, and
least so between the nasal and superior meridians. None of the
(r) ratios correlated significantly with age and degree of
ocular pigmentation.
|
Subgroup C.
The individual distributions of fluorescence along the
horizontalvertical meridians derived from spectrophotometry
(n = 7; Fig. 4
) and the average results in Table 3
(subgroup C) exhibit the same
asymmetries observed at lower eccentricities: fluorescence was
highest temporally and superiorly, and lowest inferiorly. The
fluorescence decreased in the peripapillary region and was further
reduced over the optic disc itself (
= 0.1 to 0.8 in the disc,
with a different spectrum as previously shown.34
The
fluorescence at all sites for eccentricities up to
20° (and
outside the disc area) were significantly higher than that at the
fovea. The ratios
(r) were not significantly correlated
with age, except for
(-7) on the inferior meridian that was
negatively correlated with age (
= -0.86, P =
0.03).
|
-7°; a second maximum was observed nasal to the disc at -19 to
-23° from the fovea (mean, -21 ± 2°;
= 1.52 ± 0.28). The highest maximum
(rmax) occurred along the superior and
temporal meridians, whereas the lowest occurred along the inferior
meridian (Table 3) .
Figure 5
summarizes the average results obtained in the three different series
of measurements. Starting from the central minimum, fluorescence rises
more steeply in the temporal and nasal directions than in the superior
and inferior directions. A discontinuity in distribution occurs between
the horizontal and vertical profiles at
2° from the fovea.
The fluorescence is maximal in a ring located at an eccentricity of 9
to 13°. The fluorescence along the inferior meridian is always less
than along the other meridians at the same eccentricity. By 20°
eccentricity, the fluorescence is found to be highest along the
superior and nasal meridians, followed by that along the temporal and
inferior meridians.
|
| Discussion |
|---|
|
|
|---|
Age-Related Accumulation of Lipofuscin
We found a significant age-related accumulation of lipofuscin
(Fig. 2 , Table 2
), confirming previous ex vivo1
38
39
and
in vivo12
37
40
reports that lipofuscin increases with age
(Fig. 6)
. Our results affirm the monotonic rate of increase observed in our
earlier studies12
37
and in those of von Rückman et
al.40
In contrast, earlier ex vivo observations suggested
that deposition of lipofuscin varied with age. To compare the rates of
age-related increase in fluorescence and lipofuscin, we used the ratio
of fluorescence at age 65 to that at age 25 (Fig. 6
, inset), which was
2.8 in this study (Table 2)
.
|
Ex vivo measurements of fluorescence38 39 or counts of lipofuscin granules1 in sectioned donor eyes (curves W, O, and F in Fig. 6 ) all indicated significant increases with age, but the rates of accumulation were substantially lower. Several factors (reviewed by Okubo39 ) may have contributed to an underestimate of lipofuscin accumulation in the ex vivo studies. The age-related change in fluorophore composition of the granules54 may cause an age-related increase in the fraction of fluorophores extracted by organic solvents during the embedding process. Rates determined by fluorescence were slightly higher than those determined by granule counts, possibly because fluorescence of lipofuscin granules increases with age.54
Lipofuscin and melanin granules have overlapping distributions within
the RPE cell. The concentration of melanin in the apical cytoplasm
exceeds that in the basal cytoplasm by a factor of
1.5, whereas
basal lipofuscin concentration exceeds apical concentration by
1.4.2
Microscopic measurements are made with a fixed
sampling area in central regions of the cell that are relatively free
of melanin, whereas both the excitation and emission light for in vivo
measurements will be partially absorbed by the apical layer of RPE
melanin. Whether this attenuation is affected by age depends on both
changes in absorption by melanin and changes in the relative
distribution of both pigments. The number of RPE melanin granules
decreases with age,1
but the size and optical density of
the granules increase.54
These opposing effects may
explain why no age-related changes were found in macular RPE melanin
concentration,55
optical density of the RPE (except
perhaps above age 50),2
or in reflectometric estimates of
the melanin optical density difference between the fovea and the
perifovea.51
However, even if the total optical density
does not significantly change with age, melanin distribution is
affected by age. Melanin in the first decade of life is entirely
apical, but with increasing age the distribution becomes more uniform
(by age 70, at least half of the melanin granules are embedded in
complex melanolipofuscin granules).2
56
Thus, in vivo
measurements of lipofuscin in younger eyes are more underestimated
because of screening by apical melanin, and this would result in an
exaggerated estimate of the age-related increase in lipofuscin
fluorescence measured in vivo.
If we assume that the difference between the accumulation rates
estimated from the in vivo data (curve D, Fig. 6
) and from the ex vivo
data (average of curves O and W) is entirely due to melanin, we can
estimate that melanin must have attenuated lipofuscin fluorescence 1.5
times more at age 15 than at age 65. We can calculate
F15, the fluorescence in young
subjects, with all the melanin located apical to the lipofuscin and
F65, the fluorescence in old subjects,
with the melanin uniformly intermixed with lipofuscin in the entire
cell. These fluorescences are given by:
![]() |
![]() |
is the efficiency of the lipofuscin fluorescence (per
unit length), d the total thickness of the RPE, K
and K
the extinction coefficients of
melanin53
at the excitation (
) and emission (
)
wavelength (normalized to the extinction at 500 nm), and
D500 is the melanin optical density of
the RPE at 500 nm. The latter is the same in both cases; we assume a
very thin apical layer with high concentration at age 15, and the full
thickness d with low concentration at age 65. Substituting
F65 = 1.5.
F15 (
= 550 nm,
= 650
nm), we found by successive approximation a value
D500 = 0.32 DU. For the data with
= 470 nm (curve D'), we similarly found an optical density of
D500 = 0.29 DU. These results are
consistent with the mean optical densities for the entire RPE of 0.23
DU2
and 0.35 DU53
measured ex vivo at 500 nm.
Although derived from different studies, these calculations indicate
that most of the difference in accumulation rates between ex vivo and
in vivo estimates could be accounted for by a redistribution of melanin
within the RPE cell, even though the total amount of melanin remains
constant.
Decline in Lipofuscin Fluorescence at Older Ages
The lipofuscin levels observed above age 70 were lower than would
be expected if lipofuscin accumulated at a constant rate throughout
life (Fig. 2)
. Other studies (Fig. 6)
have not detected significant
evidence that lipofuscin levels decline above age 70, although only a
few demonstrate significant increases at old age. The gradual
age-related loss of rod photoreceptors throughout
life42
57
cannot explain the sudden decrease in lipofuscin
above age 70. We cannot exclude the possibility that individuals with
higher lipofuscin content have developed AMD and are thus excluded from
this study or that individuals with the highest lipofuscin are
selectively eliminated from the study because they are less healthy at
advanced age and/or may have higher mortality rates. It is worth noting
that some of the 50- to 70-year-old subjects have very high lipofuscin
(Fig. 2) .
The decrease in fluorescence at ages > 70 could also result, in part, from an undercorrection by our lens optical density estimates.46 Although our average lens densities are slightly higher than those predicted in other studies49 50 at old age (Fig. 1) , they exhibit a slight reduction in acceleration at older age. We believe that this may indicate some underestimation of the lens optical density and is the reason why we excluded subjects with lens densities > 0.375 DU. To support a linear age-related accumulation of fluorescence up to age 80 (Fig. 2) , the extrapolated fluorescence at age 80 would need to be 1.7 times greater than that measured, on average, at age 80. This would require an incremental density of 0.3 DU (510 nm) between the ages of 65 and 80 and would double the lens density at age 80. Because this is clearly unreasonable, we can reject gross underestimation of lens absorption as the sole reason for the decline in fluorescence. Some undercorrection may exist, but we are not able to assess its magnitude; future studies comparing fluorescence before and after IOL surgery may clarify this issue.
Previous reports have shown that lipofuscin levels in those with AMD were significantly below normal subjects of the same age6 33 and that fluorescence in regions of geographic atrophy is very low.7 37 40 58 Current evidence, reviewed in the Introduction, indicates that A2E (a major constituent of lipofuscin) will cause RPE apoptosis if it is released from the lysosomes into the cytoplasm31 or if it mediates blue-light damage.27 Subsequent removal of apoptotic RPE cells would result in local reduction in lipofuscin fluorescence. The possibility that the decrease in RPE lipofuscin in older subjects represents incipient atrophy may be supported by our observation in autofluorescence imaging of substantial focal variability in fluorescence and small patches of very low fluorescence in 3 of 10 subjects (6070 years old). A more rigorous quantitative analysis is required to elucidate whether the regions of low fluorescence represent regions of reduced photoreceptor density and/or incipient atrophy.
The magnitude of the contribution of A2E to in vivo fluorescence measurements is still unknown. Emission spectra of A2E (Exc, 380 nm) in different organic and inorganic solvents have a maximum at 570 to 610 nm, and intracellular A2E has a maximum emission at 560 to 575 nm.30 Excitation and absorption maxima of A2E in the visible range occur at 430 to 450 nm, and these spectra tail down to 5% to 10% of peak at 550 nm,27 59 indicating the feasibility of measuring A2E fluorescence in vivo with excitation wavelengths as long as 550 nm (assuming moderate contributions of other lipofuscin fluorophores20 ). The dominant fluorophore that we measure in vivo exhibits maximum emission at 600 to 640 nm (dependent on excitation wavelength); this peak is expected to shift toward shorter wavelength if ocular media and melanin absorption were fully taken into account. More work needs to be done to eventually reconcile the relationships among the in vivo spectrum, the spectrum of isolated A2E (with the excitation wavelengths used in vivo), and the spectra of intact lipofuscin granules.
Spatial Distribution of Autofluorescence
Our observations confirm previous reports that lipofuscin is lower
in the fovea than in the nasal or temporal macula.2
38
Previous in vivo studies were confounded by the use of short-wavelength
excitation, which was partially absorbed by the macular
pigment35
37
; the use in this study of an excitation at
550 nm removes this limitation. Our study provides evidence that
fluorescence is not symmetrically distributed around the fovea. In all
three sets of measurements (Figs. 3
and 4
, Table 3
), we found
significantly less fluorescence along the inferior meridian than along
any other meridian. The distribution of fluorescence in the central
9° around the fovea exhibited large variability (Fig. 3)
, as was
observed in the distribution of lipofuscin in older donor
eyes.6
Asymmetries were also seen as close as 1 to 2°
from the fovea (Fig. 5) . A limitation of our study is that no
measurements were performed outside the meridians, which leaves open
the possibility that higher maxima may be located at other sites within
quadrants.
Influence of RPE Melanin and Nerve Fiber Layer
We considered whether losses of excitation light and fluorescence
through absorption by RPE melanin (discussed above) and/or scattering
by the nerve fiber layer could significantly affect the fluorescence
distribution and whether regional variation in these entities could
explain the observed asymmetries. RPE melanin is greatest at the fovea,
decreases substantially from the fovea to approximately 5°, exhibits
a broad minimum between 5 and 20°, and then increases slowly toward
the equator.2
38
53
Using a combination of reflectance and
fluorescence measurements,51
we calculated that the
optical density difference in apical melanin between the fovea and 7°
from the fovea was effectively 0.10 ± 0.08 DU at 500 nm. For an
emission at 650750 nm (Exc, 550 nm) and using known extinction
coefficients for melanin,53
this corresponds to
21%
more attenuation of lipofuscin fluorescence at the fovea than at the
perifovea. Because we measured foveal levels that are on average 65%
of the fluorescence at 7° eccentricity (Table 2)
, we estimated that
the foveal lipofuscin would actually be
78% of that at 7°
eccentricity. This is consistent with ex vivo
measurements2
that indicated that lipofuscin in the fovea
was
81% of that at an eccentricity of
7°. Thus, the depression
in the fluorescence distribution at the fovea (Figs. 3 and 5)
is
exaggerated as a result of RPE melanin absorption.
The fact that fluorescence at equal eccentricities between 2 and 7° along the horizontal meridians are higher than those along the vertical meridians (Fig. 5) could be explained if greater melanin concentrations occurred superior and inferior to the fovea. However, monochromatic fundus photographs at 570 nm,60 which delineate higher RPE melanin, are not consistent with such distribution: the area of high RPE melanin is either circular or slightly elongated horizontally. It is difficult to ascertain the role of RPE melanin at larger eccentricities: not only was the spatial resolution of ex vivo measurements of melanin38 53 too low to account for asymmetries, but information about RPE melanin along the vertical meridians is currently, to our knowledge, unavailable.
Attenuation of light by nerve fibers61 could also play a role, particularly around the optic disc. However, although there is a 1.5- to 3-fold difference in the thickness of the nerve fiber layer at 7° eccentricity in nasal and temporal meridians,62 63 there was no marked asymmetry in fluorescence at these sites. Moreover, the thicker nerve fiber observed in the superior retina62 63 could not explain the reduction of fluorescence observed in the inferior retina. Asymmetries in nerve fiber layer thickness around the fovea may match the observed asymmetries in fluorescence between the horizontal and vertical meridians (at 24° eccentricity, Fig. 5 ): the nerve fiber layer thickens more rapidly along the vertical meridians (lower fluorescence) than along the horizontal meridians (higher fluorescence).62 63 64 However, it is unclear how differences in the order of only 5 to 15 µm in nerve fiber layer thickness (at 23°) could have the observed effect on the fluorescence. Light loss by scattering by the ganglion cells, whose densities are maximal at 23° eccentricity,65 could not explain the asymmetries because their distribution does not exhibit much asymmetry at those eccentricities.
Because both absorption by melanin53
and scattering by
nerve fibers61
decrease with increasing wavelength, we
assessed, in one subject, whether the distribution obtained with
excitation at 470 nm was substantially different from that observed
with the 550-nm excitation (Fig. 7)
. All fluorescences were normalized to the fluorescence at the fovea
with excitation at 550 nm. The ratios were drastically lower in the
fovea (
0.3) because of RPE melanin (see above) and macular pigment
absorption, but the influence of macular pigment should be negligible
by 7° eccentricity.43
The 470-nm profiles were slightly
lower than the 550-nm profiles between 7 and 15° (more so
horizontally than vertically), and the ratios were about equal at 20°
eccentricity. The plots in Figure 7
argue against a large difference in
attenuation by either RPE melanin or nerve fibers at 20° and against
a differential attenuation along the superior and inferior meridians.
RPE melanin distribution may explain why the differences in
fluorescence was stronger along the horizontal meridian than along the
vertical meridians.
|
The distribution of fluorescence roughly matches that of rods at
eccentricities larger than 7° (Fig. 5)
. Maximum fluorescence along
each meridian was found inside the ring of highest rod density; the
maximum fluorescence occurred at
11°, 13°, and 9° from the
fovea on the temporal, superior, and inferior meridian, respectively,
whereas the maximum rod densities were at eccentricities of at
least
13°, 14°, and 14°, respectively. At larger
eccentricities, rod density decreased less rapidly with increasing
eccentricity than fluorescence. Several factors might contribute to
both the inward displacement of the fluorescence maxima and the higher
slope at high eccentricities. Decreases in the length of the rod outer
segment with eccentricity67
68
and in the rate of rod
outer segment renewal,69
would decrease the volume of
the phagosomes and/or reduce the formation of lipofuscin. Light
distribution at the posterior pole is unlikely to be a
factor.70
Our analysis of the age relationship of the inferiorsuperior difference in fluorescence suggested that the fluorescences were about equal at age 25 and that the fluorescence then increased significantly more slowly inferiorly than superiorly. If premature loss of photoreceptors reduces lipofuscin formation in human as it does in rats,71 72 then more rapid loss of rods in the inferior retina42 would reduce, as observed, the rate of lipofuscin accumulation in the inferior retina. Although the areas in which we found greatest lipofuscin accumulation overlap (or are slightly inside) the regions in which the rod loss was greatest (Fig. 5) ,42 maximal rod loss did not correspond with the highest fluorescence level at these sites. Indeed, the inferior retina had greater rod loss and lower fluorescence, whereas the superior retina had lower rod loss and higher fluorescence. These considerations suggest that the age-related loss of rods cannot be predicted by lipofuscin accumulation, confirming the conclusions of Curcio et al.,42 which were based on an alternate rationale.
In the central area, lipofuscin fluorescence exhibits a shallow minimum (Fig. 3) that is slightly displaced in the nasal-inferior direction by an average of 0.5°. This zone on minimal fluorescence overlaps the rod-free zone, which is also slightly displaced nasally.41 Isofluorescence contours are slightly elliptical with a long vertical axis, in contrast to rods and cones whose isodensity contours are horizontally oriented ellipses.41 Cone density is maximal in the fovea (where the density exceeds the maximal density of rods) and decreases rapidly with eccentricity: by 3.0 to 3.5° cone density is only 10% of its maximum (Fig. 5) .41 The narrowness of the cone distributions makes it impossible to reconcile the fluorescence distribution with any simple linear combination of cone and rod density distributions. The fluorescence distribution in the foveal area may also be influenced by RPE melanin distribution (mentioned above), macular pigment (discussed below), and by numerous other factors such as the variation with eccentricity of cone types, outer segment length, rate of outer segment renewal,69 and rate of lipofuscin formation in the RPE. Rod/cone differences in some of these factors will also influence the relative contributions of each photoreceptor type to the formation of lipofuscin. Anderson and colleagues73 found in Rhesus monkeys that the number of foveal (cone-derived) phagosomes in the RPE was only one third of the number of extrafoveal phagosomes (mainly rod derived), suggesting that the rate of lipofuscin formation associated with cones may be slower.
Macular pigment (lutein and zeaxanthin in cone axons) reaches peak
optical densities of up to 1.0 DU (at 460 nm) in the fovea, and its
density distribution is symmetrical and very similar to that of
cones.43
Because it absorbs blue light, macular pigment
may substantially reduce blue-lightactivated mechanisms of lipofuscin
and A2E formation (see Introduction). However, as in case of the cone
distribution, the distribution of macular pigment is also very narrow;
it reaches 10% of its peak density at 3.1 ±
1.3°.43
The depression in lipofuscin fluorescence
observed within eccentricities of
8° is thus much larger than the
area occupied by the densest macular pigment, and a simple protective
effect of the macular pigment is thus not observed in the spatial
distribution. However, approximately 70% of the total retinal lutein
and zeaxanthin is contained within the rod outer
segments,74
where they may act as
antioxidants,75
slowing the rate of lipofuscin
formation.76
77
The lutein and zeaxanthin within the outer
segments also declines with increasing eccentricity, which could
account for part of the gradual increase in fluorescence with
eccentricity. Combined measurements of the spatial density distribution
of the macular pigment51
and lipofuscin in individuals,
and a better understanding of the physiology of the lutein and
zeaxanthin in rods and cones will help resolve to what extent their
distribution controls that of lipofuscin.
The data presented here indicate that the distribution of
lipofuscin reflects, rather than predicts, the age-related loss of
photoreceptors. However, excessive accumulation of lipofuscin may
contribute to the etiology of photoreceptor atrophy in Stargardts
macular dystrophy and possibly AMD. Bulls-eye regions of atrophy in a
variety of retinal diseases, including AMD and Stargardts disease,
have been attributed to the protective effect of the macular pigment
and the ring-like region of high lipofuscin.78
In
age-related maculopathy, the distribution of soft indistinct drusen and
pigmentary abnormalities outside the central area44
roughly matches that of lipofuscin: they were more prevalent in the
superior retina (where lipofuscin fluorescence is higher) than they
were in the inferior retina (where lipofuscin in always lower).
However, soft indistinct drusen and pigmentary abnormalities were most
prevalent in the central 3° diameter region (where lipofuscin is
80% of maximal). Clearly, lipofuscin could only be one of the
multiple factors influencing susceptibility to retinal damage.
Understanding the cause and nature of the focal and global distribution
in lipofuscin fluorescence may advance the understanding of the
pathogenesis of AMD. Lipofuscin measurement may ultimately prove an
excellent screening tool to recognize subjects at high risk for AMD and
other maculopathies, and/or to evaluate new therapies targeting
accumulation and/or liberation of A2E. To further elucidate the
relationship of lipofuscin and retinal pathology, it will be necessary
to obtain the distributions of fluorescence and pathology in subjects
with age-related maculopathy and in patients with early AMD.
| Acknowledgements |
|---|
| Footnotes |
|---|
Submitted for publication December 1, 2000; revised February 21, 2001; accepted March 9, 2001.
Commercial relationships policy: N.
The publication costs of this article were defrayed in part by page
charge payment. This article must therefore be marked
"advertisement" in accordance with 18 U.S.C.
1734
solely to indicate this fact.
Corresponding author: François C. Delori, Schepens Eye Research Institute, 20 Staniford Street, Boston, MA 02114. delori{at}vision.eri.harvard.edu
| References |
|---|
|
|
|---|